EDITION OF MON 28 SEP 2026
132 · BUSINESS

FDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled

publishers 16articles 17first reported 24 Sep, 12:18 UTCdeveloping since 24 Sep · 6 editions

The Food and Drug Administration has elevated a recall of thyroid medication to its highest risk classification, according to reports from USA Today, NewsNation and News4JAX.

Separately, more than 13,000 bottles of a blood pressure medication have been recalled nationwide, according to EatingWell, WSB-TV, The Healthy and Health.com. Daily Voice also reported a major nationwide drug recall alert.

HOW THIS STORY WAS MADE

Written from 8 articles, headlines and summaries only; 8 independent newsrooms once syndicated copies count as one; this version written within the hour the record first saw the story; the editor kept it as written.

Publishers
16
Source articles
17
Given to the writer
8, headlines and summaries only
Independent newsrooms
8
This version written
within the hour the record first saw the story
Second model (editor)
kept as written
Publication gate
passed
Human review
none

WHAT THE EDITOR DID

The second model checked the writer's draft against the same sources and published it as written.

Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →

NAMED IN THE COVERAGE

OUTLETS CARRYING THE STORY, RUN BY RUN

0 8 17 25 Sep 26 Sep 27 Sep 28 Sep 29 Sep 25 Sep 00:18 UTC · FDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.

HOW THIS STORY DEVELOPED: EVERY HEADLINE, EVERY OUTLET →